Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Volume 14 Issue 4

Respiratory Disease Management: A Connected Approach

Until relatively recently, treating, monitoring and controlling respiratory conditions such as asthma centred on conventional devices, paper-based tools and appointm...
Continue Reading →
Volume 14 Issue 4

IP Issues Surrounding Machine Learning and AI in the Pharmaceutical Space

When it comes to protecting technical innovations there are two broad strategies: keep it a trade secret or obtain a patent. It has long been the case that computer-...
Continue Reading →
Volume 14 Issue 4

Strategic Intellectual Property Considerations for Protecting AI Innovations in Life Sciences

Artificial intelligence (“AI”) is all around us. It allows us to unlock our smartphones with just a glance. It can customise the temperature of our home or recommend...
Continue Reading →
Volume 14 Issue 4

Data-driven Processes Overtake Structured Document Authoring

The strategic focus in life science technology investment is shifting from documents to data. Regulators are increasingly asking for data rather than documents and d...
Continue Reading →
Volume 14 Issue 4

Pharmaceutical Tablet Coating – Achieving Perfect Coating Uniformity

Tablets are the most important oral dosage form in the pharmaceutical industry. Pharmaceutical film coating, a thin film made from one or more polymers (and usually ...
Continue Reading →
Volume 14 Issue 4

The Challenges of Increased Complexity in API Development and Manufacture

There is no getting away from it: the small molecule drugs now entering and travelling through the clinical pipeline are becoming more complex. This increasing compl...
Continue Reading →
Volume 14 Issue 4

NCEs and API – Quality by Design

The development and manufacturing of NCE and API is striving for simplifying and shortening timelines, as well as for making more efficient use of chemicals, equipme...
Continue Reading →
Volume 14 Issue 4

Demand, Design, Delivery: High Potent Packaging at PCI Pharma Services

In a fragmented marketplace, drug discovery organisations are increasingly looking to work with fewer outsourcing partners. As such, CDMOs that are able to provide t...
Continue Reading →
Volume 14 Issue 4

What’s Next for Pharmaceutical Serialisation?

Supply chains for pharmaceutical products are exceptionally complex, with medicines and ingredients often crossing the borders of many countries before reaching the ...
Continue Reading →
Volume 14 Issue 4

Overcoming the Pitfalls of Pre-filled Syringe Filling

Michael Isele, Site Manager at Recipharm, explores the pitfalls of filling and packaging in pre-filled syringe formats, from sterile integrity requirements to packag...
Continue Reading →
Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025